Concord Biotech Limited (CONCORDBIO) Share Price & AI Investment Analysis

Concord Biotech Limited, a, biopharma company, engages in the research and development, manufacture, and sale of pharmaceutical products in India and internationally. It operates through Active Pharmaceutical Ingredients (APIs) and Formulations segments. The company provides fermentation based active pharmaceutical ingredients in immunosuppressants, anti-bacterial, oncology, antifungal, and other therapeutic areas. It also offers tacrolimus, mycophenolate mofetil, mycophenolate sodium, cyclosporine, sirolimus, voclosporin, and pimecrolimus for immunosuppressants therapeutic segment; and temsir. Track Concord Biotech Limited's live NSE:CONCORDBIO share price ₹1,532.40 (-3.31%), market cap ₹₹160B, P/E 52.9. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for CONCORDBIO — real-time NSE India stock intelligence.